News
Article
Author(s):
In case you missed it, this week we had news about the FDA approval of sofpironium gel for primary axillary hyperhidrosis, Sun Pharma's "I LUV YA for the Long Haul" psoriasis campaign, the role of laser treatments in preventing cancer, and more.
To stay up-to-date with the latest dermatology news, sign up to receive our eNewsletters.
Ethan Sims, MD, spoke with Dermatology Times on having positive conversations, cutting down on waste, and how to get involved in change.
Dermatologic emergency units are increasingly overwhelmed by rising patient volumes and reduced resources, but store-and-forward teledermatology offers an effective alternative.
Omar Noor, MD, and a patient with psoriasis share their unique perspectives on moderate to severe plaque psoriasis treatment with tildrakizumab.
A recent review found that disparities and barriers, such as income, age, and location, can impede patient access to necessary care.
Cutaneous and advanced stage melanomas present significant challenges during pregnancy, according to the posters.
Sara Osborne, a fourth-year medical student and the lead author on the study, spoke with Dermatology Times on key findings and explain the need for further investigation.
In one study, less than 5% of images from a HAM10000 database came from patients with darker skin types.
In this month's Cosmetic Conundrums column, Zoe Diana Draelos, MD, examines the most popular active ingredients in redness-reducing formulations.
Rob Casquejo, PA-C, spoke with Dermatology Times on new and upcoming medications, addressing unmet needs, and social media misinformation.
Eli Lilly recently hosted a panel discussion with Olympic athlete Suni Lee to discuss the importance of finding a dermatologist who understands the burden of AD.
Patricia Richey, MD, delves into efficacy of the 1927 and 1550 nanometer lasers to prevent skin cancers.
From a financial perspective, the change from resident to attending dermatologist may be profound.
Laura Bush reflects on her term as SDPA president, discussing achievements, challenges, and the future of dermatology PAs in health care.
Individuals in Uyo, Nigeria, with albinism are at great risk of developing photodermatoses due to a lack of photoprotection and awareness of photoprotective behaviors.
Perceived stress, however, did not exhibit any correlations with psycho- and skin physiological parameters.
The authorization of DermaSensor marks a milestone in AI-enabled devices, highlighting opportunities and challenges in their integration into clinical practice.
The recent news of counterfeit Botox resulted in patients with blurred vision, difficulty swallowing, shortness of breath, and additional symptoms.
This month's Legal Eagle column explores if a dermatologist can be sued for charging a fee for providing medical records in a lawsuit.
Martin Zaiac, MD, gave insight on potential risks associated with manipulation of nails, hygiene, and when it is necessary to see a specialist.
BPO may prevent post-operative infections with limited risk of microbial resistance in surgery of sebaceous areas, according to a new study.
LC-OCT non-invasively assessed non-structural changes from botulinum toxin and irreversible tissue changes from microwave thermolysis in hyperhidrosis.
Learn more about the proven strategies to keep your pediatric patients' skin healthy and allergy-free.
Stefan Weiss, MD, MBA, explains next steps for the oral treatment after the completion of phase 1b enrollment.
Researchers noted differences in microbial evenness, abundance composition, and functional prediction.
Stephen Tyring, MD, PhD, MBA, covers the burden of antimicrobial resistance and the need for alternative treatments.
Botanix Pharmaceuticals announced the approval of its sofpironium topical gel, 12.45% for adults and children ages 9 and older.
The post-hoc analysis evaluated the relationship between lebrikizumab serum concentration levels and sustained clinical response after lebrikizumab discontinuation.